Eric Drape - 30 Jan 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Executive VP Global Operations
Issuer ticker: TEVA
Reported as of: 30 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Feb 2024, 07:22:53 UTC
Prior SEC filing: 08 Mar 2023
Next SEC filing: 21 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Dov Bergwerk as attorney-in-fact for Eric Drape

Key filing fact

Eric Drape filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 01 Feb 2024.

Key facts

This page summarizes Eric Drape's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Feb 2024, 07:22.

Change

Previous filing in this sequence was filed on 08 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TEVA transaction Derivative

Restricted Share Units

Award

Transaction value: $0
Shares: +55,226
Change %
Price: $0.000000
Shares after: 55,226
Date: 30 Jan 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 55,226
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

Footnote F2

Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 5, 2024.

Footnote F3

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.